Nanobio and Nanomedicine

The company's proprietary 'Triad' technology has applications in vaccines, cancer diagnostics, and specialty research probes. Triad combines carbohydrates and proteins on nanoparticles, which enables presentation of sugars and proteins in a controlled and logical way.

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.

Develops, manufactures, and sells a broad range of biological based materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs,including clinically annotated DNA and RNA.

The company has developed its proprietary nano-Pore Optical lnterferometry (nPOI) platform for biomolecular interaction analysis.

Sirnaomics, Inc. is dedicated to becoming the leader in the RNAi technology focusing on (1) enhancement of the potency of active pharmaceutical ingredient (API) using multi-targeted small interfering RNA (siRNA) cocktail; (2) improvement of the API delivery in vivo using clinical viable synthetic polymeric and lipid nanoparticles.

The company's technology involves the encapsulation, at room temperature, of active ingredients in micro- and nano-sized glass (silica) matrices as well as nanospheres utilizing a chemical process called sol-gel.

A drug delivery company developing enhanced and improved therapeutic medicines in several fields. Solubest is using advanced polymer formulations to prepare nanotransporters for drugs having delivery or compliance insufficiencies.

A medical device manufacturer, Soundwave Research Laboratories, Inc. has developed a proprietary Acoustic Nanofilm technology which allows them to convert many polymeric substrates into acoustic and pressure sensitive transducers.

The company develops nanoparticle-based contrast agents for diagnostic imaging with a focus on magnetic resonance imaging (MRI).

The company develops biophotonics applications for studies of human tissue objectively at the cellular and molecular level to detect, diagnose and monitor disease.

The company's Phase Inversion Nanotechnology (PIN™) enables oral and non-oral delivery of biologics, poorly soluble drugs and/or drugs with low permeability.

The company develops biosensor technology that incorporates a proprietary nanostructured optical grating,

Develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications.

Starpharma Holdings Limited is a world leader in the development of dendrimer nanotechnology products for pharmaceutical, life-science and other applications.

The company uses a proprietary nanotechnology delivery systems designed to support the environment during stem cell culturing, harvesting, differentiation and post transplantation procedures.

The company's polymer-based Biotransport™ Nano-Carriers have the ability to solubilize and transport molecules through natural barriers such as the blood-brain barrier.

The company's medical The SurgRX™ EnSeal™ System incorporates Smart Electrode Technology that consists of millions of nanometer-sized conductive particles embedded in a temperature-sensitive material.

SurModics® Synthetic ECM is a synthetic, stable, and scalable cell culture platform that provides an in vivo-like cell culture environment with its biomimetic extracellular matrix structure and surface. The technology produces results for cell research and cell-related applications. The nanofibrillar matrix utilizes Ultra-Web™ technology.